Peters William J's Form 4 filing
Amphastar Pharmaceuticals, Inc. (AMPH) · filed Mar 8, 2024
- Accession no.
- 0001415889-24-007367
- Filed
- Mar 8, 2024
- Trade date
- Mar 6, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $843.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Peters William JCIK 0001263136 | Director, Officer (CFO, EVP & TREASURER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 6, 2024 | Common Stock | MOption exerciseAcquired | +8,826 | $11.33 | +$99,998.58 | 129,626 | Direct | |
| Mar 6, 2024 | Common Stock | SSaleDisposed | −13,404 | $46.30 | −$620,605.2 | 116,222 | Direct | |
| Mar 6, 2024 | Common Stock | SSaleDisposed | −4,681 | $46.98 | −$219,913.38 | 111,541 | Direct | |
| Mar 6, 2024 | Common Stock | SSaleDisposed | −51 | $48.00 | −$2,448 | 111,490 | Direct | |
| Mar 6, 2024 | Common Stock | FTax withholdingDisposed | −2,190 | $46.31 | −$101,418.9 | 109,300 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 6, 2024 | Common Stock | MOption exerciseDisposed | −8,826 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.